SABPA 13th Annual Biomedical Forum on 4/21/2018


Home 论坛 站长信箱 SABPA 13th Annual Biomedical Forum on 4/21/2018

This topic contains 1 reply, has 1 voice, and was last updated by  Richard Chang 2 weeks, 3 days ago.

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #25003

    Richard Chang
    Participant

    Dear SABPA OC/LA friends,
    Our 13th Annual Biomedical Forum on Apr 21, 2018 (Sat) in Santa Ana, CA is coming in 3 weeks!

    This exciting forum by SABPA OC/LA will bring you the latest innovations in biomedical industries, cutting-edge developments of pharmaceuticals and medical devices, entrepreneurship and fundraising, and career development. We aim to provide an attractive platform to promote life sciences and biotechnology, connect entrepreneurs, scientists, investors and students, and stimulate alliances across biomedical industries in SoCal and Pacific Asia. Join us for the exciting learning and networking opportunities! Follow SABPA OC/LA at http://www.sabpa-ocla.org

    Please register now! Get the early bird registration before the deadline!

    See you April 21!

    SABPA OC/LA

    SABPA 13th Annual Biomedical Forum

    When: Apr 21st (Sat), 2018 8:30 AM – 4:30 PM

    Where: Double Tree by Hilton Hotel Santa Ana Orange County Airport, 201 E MacArthur Blvd, Santa Ana, CA 92707

    Registration: Early bird (before April 15) $10 for students and post-docs, general public $25; $40 onsite (Breakfast, lunch & parking included) Register here

    Keynote Speakers

    Ian Critchley, Ph.D., Vice President of Clinical Microbiology at Allergan

    The Roller Coaster of Antibacterial Drug Discovery and Development in an Era of Increasing Resistance

    Ian Critchley, Ph.D. is currently the Vice President of Clinical Microbiology at Allergan. Dr. Critchley obtained his PhD in Microbiology at the University of Glasgow, Scotland UK and has more than 30 years of experience in both antibacterial discovery research and development. In recent years Dr. Critchley’s team has managed pre-clinical and clinical microbiology studies to characterize the profiles of three approved antibiotics. Today Dr. Critchley’s team at Allergan continues to support antibacterial products that address existing and emerging resistance mechanisms.

    Dr. Cun-Yu Wang, D.D.S., Ph.D., Professor, Chair, UCLA, Member of National Academy of Medicine

    Chinese Culture, Innovation and Beyond

    Dr. Cun-Yu Wang, D.D.S., Ph.D. is the No-Hee Park Endowed Professor and Chair in Division of Oral Biology and Medicine, the Associate Dean for Graduate Studies, School of Dentistry, UCLA. He has made a landmark discovery on the regulation of cancer cell death by the transcription factor NF-κB, which was cited in one of ten important discoveries in 1996 by Science magazine. He was elected to the National Academy of Medicine as a member in 2011 and to the Chinese Academy of Engineering as a foreign member in 2013.

    王存宇博士,博士 是No-Hee公园捐赠的教授和口腔生物学和医学分部主席,牙科 学院副院长,加州大学洛杉矶分校。 他在转录因子NF-B调控癌细胞死亡方面做出了一个具有里程碑意 义的发现,1996年被“科学”杂志评为十大重要发现之一。 他于2011年当选为国家医学科学院院士,并于2013年当选为 中国工程院院士。

    Program Highlights

    ØAntibacterial Drug Discovery/Development
    ØCulture and Innovation
    ØLabeling Compliance, Regulatory Considerations
    ØOCT Technology from Bench to Bedside
    ØFrom Engineer to Business
    ØFundraising for Startups
    ØInnovation In Devices Treating Heart Valve Diseases
    ØCareer Development Roundtable

    More event details: http://www.sabpa- ocla.org/newsevent/sabpa-oc- la-13th-annual-biomedical- forum

    #25004

    Richard Chang
    Participant
Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.